35th week of 2010 patent applcation highlights part 31 |
Patent application number | Title | Published |
20100221299 | THERAPEUTIC STEM CELL NUTRIENT COMPOSITION AND USES THEREOF - The present invention relates to a composition and uses thereof for treatment of damaged tissue comprising at least one essential amino acid in L form and at least one essential lipid; wherein the composition is administered to a mammal suffering from severe tissue damage. The invention further relates to a composition and uses thereof comprising the mixture of one or more free L-amino acids in which the molar ratio of the free L-amino acids corresponds to the molar ratio of amino components in a mammalian tissue protein; and at least one essential lipid. | 2010-09-02 |
20100221300 | Processing of Angiogenic Scaffolds for Large Organ Regeneration - This invention relates to a method for fabricating large scaffolds in a variety of shapes with an organized pore structure. The pore structure is organized such that pores are generally aligned perpendicular to the edges of the scaffold, regardless of-the particular macroscopic scaffold shape. Specifically, a freeze-drying based fabrication method for creating large, polymeric porous scaffolds for tissue engineering applications, with an organized pore structure of columnar pores extending from the scaffold periphery into the main mass of the scaffold. | 2010-09-02 |
20100221301 | Method for Preparing Porous Scaffold for Tissue Engineering - The present invention relates to a method for preparing a porous scaffold for tissue engineering. It is another object of the present invention to provide a porous scaffold obtainable by the method as above described, and its use for tissue engineering, cell culture and cell delivery. The method of the invention comprise the steps consisting of a) preparing an alkaline aqueous solution comprising an amount of at least one polysaccharide and one cross-linking agent b) freezing the aqueous solution of step a) c) sublimating the frozen solution of step b). characterized in that step b) is performed before the cross-linking of the polysaccharide occurs in the solution of step a). | 2010-09-02 |
20100221302 | Delivery System For Heparin-Binding Growth Factors - A device comprising a scaffold coated with a protein having at least 83% identity to the amino acid sequence of the core protein of domain I of a mammalian perlecan, wherein at least one glycosaminoglycan is attached to the protein is described. The device may be used in vitro or in vivo to induce replication and/or differentiation of connective tissue cells and to repair tissue. | 2010-09-02 |
20100221303 | Method for Preparing Porous Scaffold for Tissue Engineering, Cell Culture and Cell Delivery - The present invention relates to a method for preparing a porous scaffold for tissue engineering. It is another object of the present invention to provide a porous scaffold obtainable by the method as above described, and its use for tissue engineering, cell culture and cell delivery. The method of the invention comprises the steps consisting of: a) preparing an alkaline aqueous solution comprising an amount of at least one polysaccharide, an amount of a cross-linking agent and an amount of a porogen agent b) transforming the solution into a hydrogel by placing said solution at a temperature from about 4° C. to about 80° C. for a sufficient time to allow the cross-linking of said amount of polysaccharide and c) submerging said hydrogel into an aqueous solution d) washing the porous scaffold obtained at step c). | 2010-09-02 |
20100221304 | Bionanocomposite Materials and Methods For Producing and Using the Same - The present invention provides bionanocomposite materials comprising at least two coaxial layers of bionanocomposites, and methods for producing and using the same. The bionanocomposite materials of the present invention comprise a core structure and a shell structure encapsulating the core structure, where one of the core structure or the shell structure comprises a porous biocompatible natural-derived material and the other comprises a biocompatible biomimetic nanostructure. | 2010-09-02 |
20100221305 | Formulations for coated microprojections containing non-volatile counterions - The invention provides for a formulation for coating one or more microprojections which reduces or minimizes the loss of counterions from the coating in order to achieve a pH-stabilized formulation. | 2010-09-02 |
20100221306 | ADHESIVE GEL SHEET FOR LIVING ORGANISMS AND SHEET FORM COSMETICS COMPRISING THE SAME - To provide an adhesive gel sheet for living organisms which may allow efficient permeation of the skin by carotenoid, and also provide a sheet-form cosmetic using the same, It is provided an adhesive gel sheet for living organisms which includes a hydrogel having a carotenoid-containing O/W emulsion, gelatin or a derivative thereof and a hydrophilic polymer, and further comprises a polyvalent inorganic salt, wherein the content of the polyvalent inorganic salt is 0.1% or less by mass of the entire mass of the hydrogel. It is preferable that the hydrophilic polymer be a polysaccharide that forms a thermoreversible gel. | 2010-09-02 |
20100221307 | ANTIVIRAL AGENTS, ANTIVIRAL FIBERS AND ANTIVIRAL FIBER STRUCTURES - Provided are antiviral agents that are effective in inactivating viruses, and fiber products and fiber structures carrying these antiviral agents. The antiviral agent effectives against influenza and comprises a metal phthalocyanine derivative represented by formula I. Fiber carries these antiviral agents. | 2010-09-02 |
20100221308 | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF - The present invention includes compositions for preventing growth and proliferation of biofilm embedded microorganisms comprising: (a) a cationic polypeptide and (b) a bis-gaunide or a salt thereof. The invention further provides methods for preparing objects with such compositions, and objects and consumables (such as household cleaners) comprising such compositions. | 2010-09-02 |
20100221309 | FILM COMPOSITIONS FOR DELIVERY OF ACTIVES - The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. Desirably, the films contain at least one active agent, which may be administered to a user topically, transmucosally, vaginally, ocularly, aurally, nasally, transdermally or orally. | 2010-09-02 |
20100221310 | MEDICAL PRODUCTS INCLUDING MODIFIED EXTRACELLULAR MATRIX MATERIALS - Described, in certain aspects, are medical products comprised of uniquely prepared remodelable extracellular matrix (ECM) materials retaining at least a portion of their native bioactivity. Also described are methods for forming and using such products. In one embodiment, an inventive product comprises a layer of remodelable ECM material modified through contact with periodic acid or a salt thereof. In some forms, such a modified ECM material layer includes non-native Schiff's base crosslinks within and/or between certain components of the ECM material (e.g., between two collagen molecules, two non-collagen molecules, and/or a collagen molecule and a non-collagen molecule). Other inventive products are comprised of various gels, foams, pastes, and formed, coherent, porous bodies at least containing ECM materials that have been modified in accordance with the present invention. | 2010-09-02 |
20100221311 | Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering - Transition metal (e.g., silver and copper) derivatized phosphorylated polysaccharides (cellulose, starch, gauze) provide antimicrobial and elastase sequestration properties to wound dressings, and the wound dressing have enhanced water sorption and elastase sequestration when used with alginates. Wound dressings with alginates (e.g., silver alginate, crosslinked alginates, etc.) provide enhanced wound fluid absorption as well as elastase sequestration. | 2010-09-02 |
20100221312 | Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering - Transition metal (e.g., silver and copper) derivatized phosphorylated polysaccharides (cellulose, starch, gauze) provide antimicrobial and elastase sequestration properties to wound dressings, and the wound dressing have enhanced water sorption and elastase sequestration when used with alginates. Wound dressings with alginates (e.g., silver alginate, crosslinked alginates, etc.) provide enhanced wound fluid absorption as well as elastase sequestration. | 2010-09-02 |
20100221313 | TRANSDERMAL RESERVOIR PATCH - A transdermal reservoir patch includes a first adhesive layer, a second adhesive layer and an occlusive backing layer configured to inhibit transport of a pharmaceutical agent from the first adhesive layer to the second adhesive layer. Methods of manufacturing the transdermal reservoir patch are disclosed. | 2010-09-02 |
20100221314 | Microneedle Device - A microneedle device having a coating including a high molecular weight pharmaceutical compound substantially uniformly is provided. | 2010-09-02 |
20100221315 | VESICULAR FORMULATIONS CONTAINING ORGANIC ACID PRODRUGS, PROCESS FOR THEIR PREPARATION - The present invention relates to vesicular formulations containing a prodrug, characterized for comprising the combination of a prodrug of weak organic acids having the following general formula: R | 2010-09-02 |
20100221316 | Encapsulated Transfer Factor Compositions and Methods of Use - Methods for stress reduction comprising administering a transfer factor to an animal. The transfer factor can be combined with glucans, such as hybrid glucans and other components, to bring about stress reduction. The formulation is encapsulated when administered to adult ruminants. | 2010-09-02 |
20100221317 | DYNAMIN MEDIATED DISEASES AND ASSOCIATED METHODS AND PRODUCTS - This invention relates generally to the treatment of cathepsin or dynamin mediated diseases, such as proteinuria, cancer, and cognitive disease and related products. Diagnostic and other assays are also provided, as well as methods for podocyte cell gene transfer. | 2010-09-02 |
20100221318 | NUCLEIC ACIDS FOR INHIBITING HAIRLESS PROTEIN EXPRESSION AND METHODS OF USE THEREOF - The present invention provides DNAzymes and ribozymes that specifically cleave Hairless protein mRNA. The present invention also provides antisense oligonucleotides that specifically inhibit translation of Hairless Protein mRNA. The present invention also provides various methods of inhibiting the expression of Hairless Protein. Finally the invention provides pharmaceutical compositions containing the instant DNAzymes, ribozymes and antisense oligonucleotides as active ingredients. | 2010-09-02 |
20100221319 | Compositions and Methods for Improved Skin Care - Compositions and methods for administering collagen to a human subject have been developed. The collagen-containing lipid vesicles of the invention provide a delivery system for human collagen which eliminates problems associated with chemical and physical instability of the collagen as well as immune responses to non-human collagen. | 2010-09-02 |
20100221320 | Active Targeting Polymer Micelle Encapsulating Drug, and Pharmaceutical Composition - The present invention provides an active targeting polymer micelle encapsulating a drug, preventing an inappropriate release of a drug which may damage a normal cell. A polymer micelle | 2010-09-02 |
20100221321 | Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses Or Conditions - A method and apparatus for delivering a plurality of medicaments in a single delivery vehicle for the management of co-morbid diseases, illnesses and conditions. The present invention provides a novel delivery process for many medicaments. Medicaments may be encapsulated and stored separately within a larger capsule until the time of ingestion, consumption, or the like. Benefits of the present invention include maintaining separation of distinct ingredients within a single capsule and the capability to control the time release of multiple ingredients within the capsule. | 2010-09-02 |
20100221323 | Crystal Entecavir Formulation And The Preparation Method Thereof - The present invention relates to a pharmaceutical composition for treating hepatitis B virus infection, comprising the crystal entecavir as pharmaceutically active ingredients and pharmaceutically acceptable excipients. The tablet and capsule of the pharmaceutical composition have more stronger stabilization than that of amorphous entecavir under conditions of lighting, high temperature and high humidity. | 2010-09-02 |
20100221325 | DIETARY SUPPLEMENT FOR HEALING OR REGRESSING SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE, GASTRITIS AND ULCERS - The current invention presents a dietary supplement obtained from a mixture of melatonin, vitamins and aminoacids for healing or regressing symptoms of gastroesophageal reflux disease (such as heartburn, regurgitation, dysphagia, coughing, hoarseness, chest pain and odynophagia), gastritis and several types of ulcerations. | 2010-09-02 |
20100221326 | PHARMACEUTICAL COMPOSITIONS FOR ORAL USE FOR TREATING PATIENTS AFFECTED BY OBESITY - Pharmaceutical compositions are for administered orally for treating patients affected by obesity. The compositions include orlistat (tetrahydrolipstatin) solubilized in pharmaceutically acceptable saturated hydrocarbons obtained from petroleum and one or more surfactants. | 2010-09-02 |
20100221327 | Nanoparticulate azelnidipine formulations - The present invention is directed to compositions comprising a nanoparticulate azelnidipine, or a salt or derivative thereof, having improved bioavailability. The nanoparticulate azelnidipine particles of the composition have an effective average particle size of less than about 2000 nm and are useful in the treatment of hypertension and related diseases. | 2010-09-02 |
20100221328 | SUSTAINED-RELEASE FORMULATIONS - Described herein are extended-release or sustained-release formulations suitable for highly soluble pharmacologically active compounds, for example, amantadine. Dosage units for providing extended release are provided by the present invention. In some embodiments, the dosage unit comprises a plurality of coated beads having drug layer and a coating layer, wherein the coating layer comprises an ethylcellulose polymer. In some embodiments, near zero-order release of the active compound is achieved. | 2010-09-02 |
20100221329 | FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE - The invention provides novel formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use in the treatment of gastrointestinal diseases and disorders, including gastrointestinal cancer. The GCC agonist formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative. | 2010-09-02 |
20100221330 | BUOYANT FORMULATIONS OF BETAINE - An oral control release formulation for releasing at least one betaine after oral administration to a human, said formulation comprising at least one pharmaceutically acceptable means ensuring an at least partial floating of the formulation releasing at least one betaine in the gastro-intestinal tractus. | 2010-09-02 |
20100221331 | PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE - The present invention provides a pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide. The composition comprises 1 to 5% colloidal silicon dioxide by weight. | 2010-09-02 |
20100221332 | METHODOLOGY AND APPARATUS FOR ORAL DUAL DELIVERY OF HOMEOPATHIC PRODUCTS AND NON-HOMEOPATHIC PRODUCTS - One possible embodiment of the invention may be an oral dosage apparatus comprising of a sealed, digestible container having an exterior that defines and seals a respective interior; the interior containing one or more non-homeopathic remedies; and the exterior presenting one or more homeopathic products. Another version of the invention may be a method of manufacturing an oral dosage apparatus comprising of the following steps of providing one or more non-homeopathic remedies and one or more non-homeopathic remedies; providing a sealed, digestible container having an exterior that correspondingly defines and seals a respective interior containing one or one or more non-homeopathic remedies; affixing one or more homeopathic remedies to the exterior. | 2010-09-02 |
20100221333 | Pellets Comprising a Core With a Water-Soluble Carrier - A pellet with a length/width ratio of less than about 1.4 is provided which comprises a core which comprises a water-soluble carrier and an active ingredient distributed homogeneously therein. The pellet disintegrates, with visually ascertainable loss of the pellet structure, into smaller fragments when the following test is carried out: (a) 200 to 800 mg of pellets are placed into a Petri dish with 0.5 ml of demineralized water. (b) The Petri dish is immediately afterwards fixed to the measuring cylinder holder of a stamping volumeter. (c) After 10 seconds, 30 stamping movements are carried out. (d) Immediately afterwards, the pellets are photographed. | 2010-09-02 |
20100221334 | COMPOSITIONS INCLUDING LEUKOTRIENE ANTAGONISTS AND NSAIDS AND METHODS OF USING THE SAME - Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs (NSAIDs) and modified NSAIDs and leukotriene antagonists and methods for using such pharmaceutical compositions are provided herein. In a preffered embodiment naproxene 2-(methanesulfonyl)-ethyl ester is used in combination with Zileuton. | 2010-09-02 |
20100221335 | SUSTAINED-RELEASE PREPARATION AND METHOD FOR PRODUCING THE SAME - The present invention provides a preparation which is a sustained-release preparation capable of providing a dissolution profile that permits once-daily administration even in the case of a highly water-soluble drug, and which can exhibit stable drug dissolution behavior and can be reduced in its size; and a method for producing the same. A preparation containing a highly water-soluble drug, a gel-forming polymer, and a low-melting lipophilic substance is usable as a sustained-release preparation that permits once-daily administration, and enables reduction in its size and simple production thereof, and thus, the objects have been achieved. | 2010-09-02 |
20100221336 | METHOD OF TREATING ARTHRITIS, PAIN OR INFLAMMATION WITH NAPROXEN 2(METHANESULFONYL)ETHYL ESTER AND A PROTON PUMP INHIBITOR - Embodiments of the present invention provide methods of treating pain, arthritis and inflammation comprising administering naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor. Further embodiments provide pharmaceutical compositions comprising naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor. | 2010-09-02 |
20100221337 | METHOD OF TREATING ARTHRITIS, PAIN OR INFLAMMATION WITH NAPROXEN 2(METHANESULFONYL)ETHYL ESTER AND AN H2 RECEPTOR ANTAGONIST - Embodiments of the present invention provide methods of treating pain, arthritis and inflammation comprising administering naproxen 2(methanesulfonyl)ethyl ester and an H2 receptor antagonist. Further embodiments provide pharmaceutical compositions comprising naproxen 2(methanesulfonyl)ethyl ester and an H2 receptor antagonist. | 2010-09-02 |
20100221338 | Coated Tablets Of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-- Dihydro-5H-Pyrrolo[3,4-b]Pyrazine And Methods For Measuring Effectiveness Of Coating - Coated tablets of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) are provided. The tablets minimize the perceived bitterness of the medicament. A method for analyzing instantaneous dissolution of sub-microgram quantities of core material is also disclosed. | 2010-09-02 |
20100221339 | Use of a combination of morphine and at least one opiate antagonist to treat opiate dependency and prevent non-oral opiate abuse among opiate addicts - The present invention relates to the use of an inseparable combination of morphine and at least one opiate antagonist with a bioavailability of less than 5% on oral administration for producing a medicament to be administered orally for treatment of opiate dependency in humans and to the use of an inseparable combination of an opiate and at least one opiate antagonists with a bioavailability of less than 5% on oral administration for producing a medicament to be administered orally for prevention of non-oral opiate abuse in opiate addicts. | 2010-09-02 |
20100221340 | METHOD AND COMPOSITIONS FOR TREATMENT OR PREVENTION OF INFLAMMATORY CONDITIONS - Pharmaceutical compositions and methods for treating or preventing an inflammatory condition in a patient are disclosed. The pharmaceutical compositions and methods include the use of vincamine or a vincamine derivative, either alone or in combination with one or more additional therapeutic agents, including a steroid (preferably a corticosteroid), an angiotensin II receptor (type 1) antagonist, an angiotensin-converting enzyme (ACE) inhibitor, and a non-steroidal anti-inflammatory drug. | 2010-09-02 |
20100221341 | Alanine-Based Peptide Hydrogels - The present invention includes a method of preparing a hydrogel of a selected viscosity. The present invention further includes a method of promoting controlled release of a biomolecule into a medium using a hydrogel of a selected viscosity. | 2010-09-02 |
20100221342 | COMPOSITION AND METHOD OF TREATING A SORE THROAT - A composition comprising an antacid, and a local, topical anesthetic. The composition is used to relieve pain or discomfort associated with a sore throat, and therefore, the invention is also directed to a method of alleviating the pain or discomfort associated with a sore throat comprising instructing a human to orally administer the composition. | 2010-09-02 |
20100221343 | COMPOSITIONS AND METHODS OF MAKING BRITTLE-MATRIX PARTICLES THROUGH BLISTER PACK FREEZING - The present invention includes compositions and methods for treating and delivering medicinal formulations using an inhaler. The composition includes a space filled flocculated suspension having one or more flocculated particles of one or more active agents and a hydrofluoroalkane propellant. A portion of the one or more flocculated particles is templated by the formation of hydrofluoroalkane droplets upon atomization and the templated floc compacts upon the evaporation of the hydrofluoroalkane propellant to form a porous particle for deep lung delivery. | 2010-09-02 |
20100221344 | Functionalized Nanoceria Composition For Ophthalmic Treatment - The invention provides a composition comprising a plurality of nanoceria particles, a sufficient amount of at least one inhibitor of human carbonic anhydrase II associated with said plurality of nanoceria particles, and a pharmaceutically acceptable carrier containing said plurality of nanoceria particles with associated inhibitor. One preferred inhibitor of human carbonic anhydrase II comprises 4-carboxybenzene sulfonamide. The disclosed composition is useful in treatment of glaucoma. | 2010-09-02 |
20100221345 | OSTEOGENIC BIOMATERIAL CONTAINING OSTEOGENESIS PROMOTING SUBSTANCE AND NANOGEL - An object of the present invention is to provide an osteogenic biomaterial which achieves long-term sustained release and localized functional expression of a substance which promotes the formation of bone tissue. The present inventors have found out that a nanogel efficiently encloses an osteogenesis promoting substance to suppress the substance from diffusion into blood, and that the nanogel functions as a carrier for local administration of the osteogenesis promoting substance. Furthermore, they have found out that the osteogenesis promoting substance-containing nanogel can be cross-linked with a water-soluble polymer to allow sustained release of the osteogenesis promoting substance at a local area over a long period of time. Based on these findings, the present invention was completed. The osteogenic biomaterial of the present invention which contains the osteogenesis promoting substance and the nanogel shows osteogenesis promoting activity over a long period of time, and can be used as a preventive and therapeutic agent against bone diseases. | 2010-09-02 |
20100221346 | Method For Transfecting Cells Using A Magnetic Field - Described is a method for transfecting a cell comprising bringing a complex comprising vector(s) and magnetic particle(s) in contact with a cell by applying a magnetic field and methods of treatment using said method. Furthermore, described is such a complex as well as methods for making it. Finally, pharmaceutical compositions, uses of such complexes and a kit are described. The method described is particularly useful where automatizable high-throughput transfection is required for large scale screening processes. | 2010-09-02 |
20100221347 | ENHANCING SOLUTE TRANSPORT WITHIN A TISSUE SCAFFOLD - This document provides materials and methods related to tissue scaffolds for use in replacing or augmenting various tissues in the body. For example, flexible tissue scaffolds with controlled pore geometry and methods of enhancing solute transport using rhythmic compression (e.g., 1.0 Hz) of tissue scaffolds are provided | 2010-09-02 |
20100221348 | THERAPEUTIC USES OF DUNALIELLA POWDER - A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude | 2010-09-02 |
20100221349 | NUCLEIC ACID CONSTRUCTS - A nucleic acid construct comprising a chimeric promoter sequence and a cloning site for insertion of a coding sequence in operable linkage with the chimeric promoter, wherein the chimeric promoter sequence comprises: (a) a Hcmv immediate early promoter sequence; (b) exon 1 and at least a part of exon 2 of the hCMV major immediate early gene; and (c) a heterologous intron provided in place of the intron A region of the hCMV major immediate early gene. | 2010-09-02 |
20100221350 | DERMATOLOGICAL COMPOSITIONS COMPRISING VITAMIN D LIPID VESICLES - Dermatological/pharmaceutical compositions contain lipid vesicles dispersed in a hydrophilic phase, such vesicles including at least one vitamin D compound and particularly calcitriol, and are useful for the treatment of dermatological pathologies, notably psoriasis. | 2010-09-02 |
20100221351 | Controlled Drug Delivery Using a Thermally Responsive Nanocapsule to Augment Cryoablation - In accordance with certain embodiments of the present disclosure, A method for intracellular delivery of cytotoxin in combination with cyoablation is provided. The method includes encapsulation of one or more cytotoxins in a thermally responsive nanocapsule by decreasing the temperature of the nanocapsule to increase the permeability of the nanocapsule whereby the one or more cytotoxins are sucked into or diffuse into the nanocapsule. The temperature of the nanocapsule is increased and the nanocapsule is delivered into a cell. Cryoablation is performed in proximity to the cell resulting in the release of the one or more cytotoxins from the nanocapsule into the cell. | 2010-09-02 |
20100221352 | PHARMACEUTICAL COMPOSITION FOR THE ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE - A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (C | 2010-09-02 |
20100221353 | Pharmaceutical Composition For Once-A-Day Administration of Trospium Chloride - A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (C | 2010-09-02 |
20100221354 | PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE - A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (C | 2010-09-02 |
20100221355 | PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE - A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (C | 2010-09-02 |
20100221356 | PHARMACEUTICAL COMPOSITION FOR ONCE A DAY ADMINISTRATION OF TROSPIUM CHLORIDE - A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (C | 2010-09-02 |
20100221357 | DRUG DELIVERY PRODUCT AND METHODS - The present invention provides a particulate delivery system comprising an extracted yeast cell wall comprising beta-glucan, a payload molecule and a payload trapping molecule. The invention further provides methods of making and methods of using the particulate delivery system. | 2010-09-02 |
20100221358 | Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders - The invention relates to novel synthetic derivatives of β-glycolipids and uses thereof as immunomodulators. More particularly, the invention relates to synthetic derivatives of β-glycolipids, specifically, the compounds of any one of Formula I, II III and IV or any mixture or combination thereof, and particularly the ALIB-97 (Formula II) derivative and uses thereof for the treatment of different pathologic disorders, particularly, immune-related hepatic disorders and pathologies associated with the metabolic syndrome. | 2010-09-02 |
20100221359 | Solid Compositions Containing Combinations of Lactoferrin, Colostrm, and Citrus Pectin - A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing. Comprising colostrum, lactoferrin, and with modified citrus pectin as an optional component, the dietary supplement is administered in mucosal delivery format a dosage form that promotes effective absorption through the lining of the oral cavity. | 2010-09-02 |
20100221360 | SILVER-CONTAINING INORGANIC ANTIBACTERIAL - The present invention provides a silver based inorganic antibacterial agent excellent in heat resistance and chemical resistance, lowered in resin coloring and excellent in processability. The present invention has been completed by finding out that problems can be solved by a silver ion-containing zirconium phosphate represented by the following general formula (1) which is produced by a wet synthesis under specific production conditions. | 2010-09-02 |
20100221361 | STABLE OXIDIZING BROMINE COMPOSITION, METHOD OF MANUFACTURE AND USE THEREOF FOR BIOFOULING CONTROL - A stable oxidizing bromine biocidal composition comprising at least one stable oxidizing bromine compound that is prepared from at least one oxidizing chemical reagent, at least one bromide source and at least one bromine or halogen stabilizer, wherein the molar ratio of bromide source to stable oxidizing bromine compound is at least about 2.1, methods of making the composition and methods of using the composition as a biocide in aqueous systems. | 2010-09-02 |
20100221362 | STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING SYNTHETIC PHOSPHORYLATED PEPTIDES - Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12 (also indicated herein as GAP10). The compositions are useful in pharmaceutical and nutraceutical formulations. | 2010-09-02 |
20100221363 | PROCESS FOR THE PRODUCTION OF A STORAGE STABLE FUNGICIDAL EXTRACT OF GLYCYRRHIZA GLABRA FOR THE CONTROL OF PHYTOPATHOGENIC FUNGI AND OTHER PLANT DISEASES - Plant diseases of crops cause huge economic losses in agricultural and ornamental production as well as in public green. Effective management and control of the disease is a major problem and a big challenge for the agricultural production. Applications (in the form of sprays) of extracts derived preferably from the aboveground parts of the | 2010-09-02 |
20100221364 | COMPOSITIONS AND METHODS OF INDUCING HAIR GROWTH UTILIZING COTINUS COGGYGRIA - This application relates to compositions and methods for inducing hair growth and improving hair quality utilizing extracts of | 2010-09-02 |
20100221365 | USE OF GINSENG FRACTIONS FOR PREVENTING OR REDUCING HEMATOLOGICAL MALIGNANCIES - The invention is directed to ginseng fractions, methods of preventing or reducing hematological malignancies such as leukemia, and methods of elevating NK cells in a subject by administering to the subject an effective amount of a ginseng fraction, a pharmaceutical composition comprising the fraction in combination with another medicament or with one or more pharmaceutically acceptable carriers including food items. The fraction may be made from | 2010-09-02 |
20100221366 | Composition For Prevention And Treatment Of Alzheimer's Disease - This invention presented is composition and method for the treatment and prevention of Alzheimer's disease, the composition comprises monacolins, anti-inflammation agents and anti-oxidant compounds extracted extracted from | 2010-09-02 |
20100221367 | USE OF SOLIDAGO VIRGAUREA IN THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS - A method for treating H5N1 avian influenza caused by H5N1 avian influenza virus in an animal by administering to an animal suffering from H5N1 avian influenza, a pharmaceutical composition of | 2010-09-02 |
20100221368 | Methods for Inhibiting Cytokines - A method for inhibition a cytokine, transgluaminase type 2 (TG2) or matrix metalloproteinase 9 (MMP-9) was provided. | 2010-09-02 |
20100221369 | NATURAL HAIR CARE COMPOSITION, METHODS FOR OBTAINING THE SAME AND USE THEREOF - Disclosed is a natural hair care composition comprising extract of flowers of plant | 2010-09-02 |
20100221370 | POLAR ORGANIC EXTRACT OF EURYCOMA LONGIFOLIA - The present invention provides a composition including a polar organic extract of | 2010-09-02 |
20100221371 | SOPHORAE RADIX EXTRACT FOR PREVENTION AND TREATMENT OF RESPIRATORY DISEASES - The present invention relates to an extract isolated from Sophorae Radix useful for prevention and treatment of respiratory diseases. More specifically, the present invention relates to a pharmaceutical drug comprising the Sophorae Radix extract having excellent effects of inhibiting airway contraction, respiratory infections, 5-lipoxygenase activity, phosphodiesterase 4 activity, airway hyper-responsiveness and airway remodeling; antagonistic activity against leukotriene D4; and an antitussive effect, thus being useful for prevention and treatment of respiratory diseases such as asthma, acute or chronic bronchitis, allergic rhinitis, acute upper respiratory infections and acute lower respiratory infections, and the like. | 2010-09-02 |
20100221372 | WOLFBERRIES AND SKIN INFLAMMATION - The present invention relates in general to the field of inflammation. In particular the present invention relates to the use of natural compounds for the preparation of a product to treat or prevent inflammation. For example an extract of wolfberry was shown to have anti-inflammatory properties. One embodiment of the present invention relates to the use of a primary composition comprising wolfberries or a part thereof for the preparation of a product to treat or prevent inflammation. | 2010-09-02 |
20100221373 | MOLD HEATING/COOLING STRUCTURE - A mold heating/cooling structure for a mold configured with a die base and an insert, comprising: a heat insulating layer, disposed surrounding a die impression of the die base for insulating the heat conduction between the die base and the insert; a magnetic powder layer, disposed against the heat insulating layer; a coil, being disposed on the magnetic powder layer in a manner that it is circling from the outside in toward the center of the magnetic powder layer; and a cooling plate, configured with a plurality of second fluid channels provided fro a fluid to flow therein. With the aforesaid structure, the insert can be heated directly by the coil the it is subject to a high-frequency current, and the heated coil as well as the insert can be cool down with high efficiency as soon as the fluid is fed into the second fluid channels. | 2010-09-02 |
20100221374 | Modular tablet press and coater - A processing unit preferably includes a tablet press module for producing and compressing tablets and a coating module for coating the tablets with a solution or a suspension. The processing unit includes a housing and a motor and one or more coating modules and tablet press modules that are removably connected with respect to the housing and the motor. The processing unit may include a single platform accommodating a single interchangeable module or dual interchangeable modules so that both compression and coating may be accomplished in a single platform. | 2010-09-02 |
20100221375 | Extrusion/Dispensing Systems And Methods - A device for extruding/dispensing materials on a substrate includes a housing with at least two channels formed to facilitate flow. The housing includes entrance ports for each of the channels for receiving different materials. The housing further includes an exit port for co-extruding the materials on the substrate to generate a relatively fine feature with a relatively high aspect ratio. | 2010-09-02 |
20100221376 | APPARATUS OF MANUFACTURING PIPE-SHAPED INSULATOR - Disclosed is an apparatus of manufacturing a pipe-shaped insulator, wherein a thin fiberglass mat is coated, at a surface thereof, with a binder (adhesive) and is press-wound on a forming roller, so as to manufacture a pipe-shaped insulator having a predetermined thickness and a predetermined diameter. The apparatus includes a mat feeding roller, a plurality of fiberglass mat transportation rollers, a coating roller to coat a binder over a surface of the fiberglass mat, a forming roller on which the fiberglass mat, coated with the binder, is wound in plural times to form a pipe-shaped insulator, a squeeze roller disposed parallel to the forming roller, a pressure regulator to press the fiberglass mat, an encoder to measure a transported length of the fiberglass mat, a cutting unit to diagonally cut the fiberglass mat, a control system, a sensor, and a plurality of drive motors and power transmission members. | 2010-09-02 |
20100221377 | SHEET OR FILM OBLIQUE STRETCHING METHOD AND SHEET OR FILM CLIPPING STRETCHER - Clipping both right and left side edge parts of a sheet or film by right and left pitch-variable clips having flow-directional clip pitches variable along with travel movements, respectively, having positions (AR, AL) for initiation of enlargements of flow-directional clip pitches changed between right clips and left clips, and enlarging flow-directional clip pitches along with travel movements of clips to thereby make an oblique stretch. | 2010-09-02 |
20100221378 | FLEXIBLE CARRIER MOLD - A carrier mold having prongs that produces shaped tampons is provided. When subjected to pressure the prongs of the carrier mold flex to completely or substantially close one end of the carrier mold. A method of forming a shaped tampon using the carrier mold is also provided. | 2010-09-02 |
20100221379 | EJECTOR APPARATUS - An ejector apparatus moves a lift core extending through a core of a component of a resin molding mold to form an undercut portion in a molded piece and is installed so as to be capable of moving obliquely with respect to the core surface in a longitudinal direction. An ejector plate is arranged between the core and a base plate below the core, so as to be capable of moving up and down. A slide path is formed in the ejector plate extending in a direction in which a lower end of the lift core makes relative horizontal movement during ascent and descent of the lift core. A slide base is movably arranged in the slide path and coupled to the lower end of the lift core. A guide rod imparts a moving force within the slide path to the lower end of the lift core during ascent and descent of the ejector plate. | 2010-09-02 |
20100221380 | Expandable cavity for injection molding tool - An injection molding tool having a first section moveable with respect to a second section. In a first position, the first section contacts the second section along a parting line and forms a cavity. An expandable cavity part is moveably mounted with respect to the second section. In a closed condition, the expandable cavity part is in a retracted or molding position. The expandable cavity part can be moved away from the molding position or the closed condition to a release position or an expanded condition with allows access to molded part or other article. A core pin is either moveably mounted with respect to the expandable cavity part or is in a fixed position with respect to the expandable cavity part. | 2010-09-02 |
20100221381 | METHODS FOR PRODUCING AN ALGINATE CROSSLINK COATING OF A WET INGREDIENT - Methods for producing an encapsulated bead comprising a droplet of a wet ingredient coated by a water-insoluble, alginate-based gel. The alginate-based coating comprises a plurality of pores having a diameter sufficient to allow the wet ingredient contained within each encapsulated bead to leach therethrough when placed within a solution. The methods for producing an encapsulated bead generally comprise the steps of preparing a first solution comprising an alginate and a first solvent and a second solution comprising a multivalent salt and a second solvent, and causing liquid drops of the first solution to come into contact with the second solution. | 2010-09-02 |
20100221382 | CELL WALL DERIVATIVES, THEIR PREPARATION PROCESS, AND USE THEREOF - In a first aspect, the present invention relates to a method for isolating cell wall derivatives from fungal or yeast biomass. According to this method, chitin polymers or chitin-glucan copolymers can be obtained. In another aspect, the invention relates to a method for preparing chitosan from chitin. The invention further relates to chitin polymers, chitin-glucan polymers and chitosan polymers obtainable by the methods according to the invention. Moreover, the invention relates to the use of chitin polymers, chitin-glucan copolymers or chitosan polymers obtainable by the method according to the present invention in medical, pharmaceutical, agricultural, nutraceutical, food, textile, cosmetic, industrial and/or environmental applications, and in particular of chitin-glucan copolymers used as a technological additive for treating a food-grade liquid or in orally administered compositions. | 2010-09-02 |
20100221383 | GENE ENCODING GLYCOGEN BRANCHING ENZYME AND USE THEREOF - The present invention relates to a gene encoding glycogen branching enzyme and use thereof, in particular, a yeast for practical use with superior resistance property to dryness and/or low-temperature storage, alcoholic beverages produced with said yeast, and a method for producing said beverages. More particularly, the present invention relates to a yeast, whose resistance property to dryness and/or resistance property to low-temperature storage is enhanced by amplifying expression level of GLC3 gene encoding a glycogen branching enzyme Glc3p in brewer's yeast, especially non-ScGLC3 gene specific to a lager brewing yeast and to a method for producing alcoholic beverages with said yeast, etc. | 2010-09-02 |
20100221384 | TREATMENT OF CEREAL FLOUR AND SEMOLINA FOR CONSUMPTION BY CELIAC PATIENTS - The present invention relates to the use of an enzymatic method for treating flour, semolina and protein extracts derived from cereals known to stimulate a pathological immune response in patients affected by Celiac Disease (CD). Said treatment drastically reduces or completely eliminates the toxicity of gluten or similar products derived from other cereals. The method uses the catalytic activity of microbial transglutaminase and, in particular, its ability to bind proteins in cereal flour or semolina to an alkylated (C | 2010-09-02 |
20100221385 | ASPARAGINASES - The invention relates to new asparaginases having improved properties, preferably improved thermotolerance, such as improved activity at high temperatures and/or improved thermostability. The invention also relates to DNA sequences encoding such improved asparaginases, their production in a recombinant host cell, as well as methods of using the asparaginases, in particular for reduction of acrylamide in foods. The invention furthermore relates to methods of generating and preparing asparaginase variants having improved properties. | 2010-09-02 |
20100221386 | MILK REPLACER - A composition comprising at least one polyol and at least one emulsifying starch has use as a milk replacer in the production of food products such as dairy products, bakery products, confectionery and convenience food products. Also disclosed is a milk replacer composition which comprises at least one polyol, at least one emulsifying starch and at least one fat. The emulsifying starch is, preferably, an n-alkenyl succinate starch, more preferably n-octenyl succinate starch. The polyol is preferably selected from sorbitol, maltitol and mixtures thereof. | 2010-09-02 |
20100221387 | HYDROLYZED CORN GLUTEN MEAL AND METHODS FOR MAKING THE SAME - Disclosed herein are methods of making hydrolyzed proteins by enzymatic conversion. The methods provide a process for producing enzyme hydrolyzed corn gluten meal. In some embodiments, the methods utilize a multistep process using various enzyme cocktails to produce corn gluten meal with improved degree of hydrolysis and solubility. | 2010-09-02 |
20100221388 | INSTANTLY SOLUBLE COMPOSITIONS FOR CALCIUM FORTIFICATION OF BEVERAGES - The invention provides soluble calcium supplement compositions that provide a clinically significant amount of calcium and optionally sweeteners and/or vitamins, while overcoming the issue of calcium-mediated coagulation in casein-containing beverages, such as coffee or tea with milk, and the issue of visible calcium oxalate particle formation in oxalate-containing beverages, such as black tea. Also provided are prepackaged articles containing the compositions of the invention in multiple and single beverage amounts and methods of using said compositions. | 2010-09-02 |
20100221389 | Drinking Straw - A combination of a container in which is disposed a liquid composition in the form of a beverage or liquid food and a drinking straw comprises a hollow elongate tube through which liquid may be drawn by suction. The tube has an outer surface and an inner surface. The combination includes an iron component and an oxidisable oil. The iron component is disposed inside the drinking straw and the oxidisable oil is in the liquid composition. The straw alone is also an aspect of the invention. | 2010-09-02 |
20100221390 | RAISED TRAY WITH MOULDED CANAL - The present invention is a horizontal base for stabilizing vertically extending walls comprising a tray surface elevated from said base, the tray surface defining at least one moulded canal of a pre-defined shape, the at least one moulded canal being defined to receive at least one of said vertically extending walls. The base is preferably used in arts and crafts endeavours and in particular, for improved efficiency in the construction of gingerbread-based structures such as gingerbread houses. | 2010-09-02 |
20100221391 | DUAL OVENABLE FOOD PACKAGE HAVING A THERMOFORMABLE POLYESTER FILM LID - The invention provides an ovenable vacuum skin package for storage and cooking of a food product. The package includes a receptacle and a thermoformable composite polymeric film cover heat-sealed thereto, and the composite polymeric film cover includes: (i) a thermoformable substrate layer comprising a first copolyester material; and (ii) on a surface of the substrate layer, a heat-sealable layer comprising a second copolyester material, the second copolyester material being different from the first copolyester material; wherein i. the receptacle comprises on a surface thereof a sealing region adapted to contact and form a scal with the heat-sealable layer; and ii. both the receptacle and the cover film comply with the requirements of paragraph h(1) of CFR §177.1630. | 2010-09-02 |
20100221392 | METHOD FOR FOAMING FOOD BY USING NITROUS OXIDE AS FOAMING AGENT - A container ( | 2010-09-02 |
20100221393 | Resealable, Reusable Plastic Storage Container and Lid With Gas-Permeable Membranes for Modified Storage of Food and Perishables - A system and reusable plastic container for preserving the quality of a range of fruits and vegetables are provided. The container independently maintains modified atmospheres and relative humidity within the range of 1% to 50% carbon dioxide plus 1% to 15% oxygen and relative humidity of 75% RH and 100% RH. For produce highly susceptible to mould, yeast and/or bacterial growth at RH of 75% to 80% will result in optimum quality retention. The container includes a plastic body, plastic lid and a gas permeable film membrane hermetically sealed between the lid and the container. The plastic body and lid can be polyamide (nylon 6, 11, 12, or 66 and blends thereof), polycarbonate, polyethylene, polyethyleneterepthalate, polypropylene, polystyrene, polyvinylchloride, and mixtures thereof. The lid can be macro-perforated for a three piece application or micro-perforated for a two piece application. The film membranes can have different oxygen and carbon dioxide permeability rates for specific package volumes and specific produce respirations. | 2010-09-02 |
20100221394 | METHOD AND DEVICE FOR SUPPLYING HOT WATER - The invention relates to a method for preparing drinks by supplying hot water for a hot drinks dispenser by means of a liquid transport circuit ( | 2010-09-02 |
20100221395 | Apparatus and Method for Predicting Meat Tenderness - An apparatus and method for predicting meat tenderness, particularly with respect to raw meat, is disclosed. The invention does not require the removal or destruction of any cuts of meat from the carcass to which the method is applied. The method allows for the identification of tender meat product that might not be identified as tender using conventional United States Department of Agriculture quality grading methods. The method includes the insertion of one or more blunt, flat-tipped blades into a meat sample, measuring a value such as stress, force, or energy upon insertion of the blade, and calculating a tenderness factor therefrom based on a tenderness threshold. | 2010-09-02 |
20100221396 | Protein crisps and method of manufacturing same - A whey protein crisp comprised of whey protein isolate, whey protein concentrate, and a binder, dry blended and mixed with water and introduced into an extruder which forms tubular whey protein strips which are cut to size and then dried. The protein crisp may optionally include a flavoring and/or a sweetener. | 2010-09-02 |
20100221397 | METHOD FOR PRODUCING A PREPARED FOOD PRODUCT HAVING A REDUCED CONTENT OF SPECIES - This invention relates to the treatment of a prepared food product or an intermediate product for a prepared food product having a reduced content of species and a product hereof. In particular the method relates to a method of producing healthier and tastier food products without losing the mechanical integrity of such products. The method involves post-processing of prepared foods by at least one treatment by a fluid at supercritical conditions, and generally results in products having a reduced fat content and/or reduced content of other species. | 2010-09-02 |
20100221398 | PRESERVATIVE - The invention relates to use of a compound of Formula (I) as a preservative, or to enhance the anti-mould efficacy of another preservative and a product comprising a compound of Formula (I), wherein: the second carbon is optionally substituted; the bond between R and the second carbon is unsaturated; R is a C | 2010-09-02 |
20100221399 | Method and Apparatus for manufacturing Graphic Art Chocolate - This invention is a method for manufacturing Graphic Art Chocolate what is designed drawings and/or photographic, letters, and printed through a edible transfer sheet using various color of chocolate ink or edible ink, using an apparatus for folding Graphic Art Chocolates and a new system of Both Side Mold. | 2010-09-02 |
20100221400 | ENGINEERING LIPIDS IN VEGETATIVE TISSUES OF PLANTS - The present invention discloses gene targets and methods for the genetic control of lipid accumulation in vegetative (non-seed) portions of plants. Enhanced lipid, e.g. triacylglycerol (TAG), accumulation in vegetative portions of plants may be obtained by down-regulation of activity of At4g24160 or a homolog thereof. Plants, plant parts, seeds comprising down-regulated AT4G24160 activity, or activity of a homolog thereof, are also provided, as well as products prepared therefrom. | 2010-09-02 |